No takes yet. Share an insight, caveat, or question.
Randomized trial reveals the structure and function of UL9 in HSV-1, suggesting targets for antiviral drug development.
Huang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: